Literature DB >> 23926184

1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Kevin K Frick1, John R Asplin, Nancy S Krieger, Christopher D Culbertson, Daniel M Asplin, David A Bushinsky.   

Abstract

The inbred genetic hypercalciuric stone-forming (GHS) rats exhibit many features of human idiopathic hypercalciuria and have elevated levels of vitamin D receptors (VDR) in calcium (Ca)-transporting organs. On a normal-Ca diet, 1,25(OH)2D3 (1,25D) increases urine (U) Ca to a greater extent in GHS than in controls [Sprague-Dawley (SD)]. The additional UCa may result from an increase in intestinal Ca absorption and/or bone resorption. To determine the source, we asked whether 1,25D would increase UCa in GHS fed a low-Ca (0.02%) diet (LCD). With 1,25D, UCa in SD increased from 1.2 ± 0.1 to 9.3 ± 0.9 mg/day and increased more in GHS from 4.7 ± 0.3 to 21.5 ± 0.9 mg/day (P < 0.001). In GHS rats on LCD with or without 1,25D, UCa far exceeded daily Ca intake (2.6 mg/day). While the greater excess in UCa in GHS rats must be derived from bone mineral, there may also be a 1,25D-mediated decrease in renal tubular Ca reabsorption. RNA expression of the components of renal Ca transport indicated that 1,25D administration results in a suppression of klotho, an activator of the renal Ca reabsorption channel TRPV5, in both SD and GHS rats. This fall in klotho would decrease tubular reabsorption of the 1,25D-induced bone Ca release. Thus, the greater increase in UCa with 1,25D in GHS fed LCD strongly suggests that the additional UCa results from an increase in bone resorption, likely due to the increased number of VDR in the GHS rat bone cells, with a possible component of decreased renal tubular calcium reabsorption.

Entities:  

Keywords:  calcium; intestinal absorption; kidney stones; vitamin D

Mesh:

Substances:

Year:  2013        PMID: 23926184      PMCID: PMC3798725          DOI: 10.1152/ajprenal.00296.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  60 in total

1.  Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.

Authors:  J Yao; P Kathpalia; D A Bushinsky; M J Favus
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

2.  Increased plasma concentrations of total and free 1,25-(OH)2D3 in calcium stone formers with idiopathic hypercalciuria.

Authors:  P Bataille; R Bouillon; A Fournier; H Renaud; J Gueris; A Idrissi
Journal:  Contrib Nephrol       Date:  1987       Impact factor: 1.580

3.  Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats.

Authors:  N S Krieger; V M Stathopoulos; D A Bushinsky
Journal:  Am J Physiol       Date:  1996-07

4.  Sex modifies genetic effects on residual variance in urinary calcium excretion in rat (Rattus norvegicus).

Authors:  Guy M L Perry; Keith W Nehrke; David A Bushinsky; Robert Reid; Krista L Lewandowski; Paul Hueber; Steven J Scheinman
Journal:  Genetics       Date:  2012-05-02       Impact factor: 4.562

Review 5.  Genetic hypercalciuria.

Authors:  Orson W Moe; Olivier Bonny
Journal:  J Am Soc Nephrol       Date:  2005-02-02       Impact factor: 10.121

6.  Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.

Authors:  Alexander J Karnauskas; Johannes P T M van Leeuwen; Gert-Jan C M van den Bemd; Paru P Kathpalia; Hector F DeLuca; David A Bushinsky; Murray J Favus
Journal:  J Bone Miner Res       Date:  2004-11-29       Impact factor: 6.741

7.  Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria.

Authors:  Murray J Favus; Alexander J Karnauskas; Joan H Parks; Fredric L Coe
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

8.  Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats.

Authors:  D A Bushinsky; A C Michalenka; K L Strutz; S Donahue; J R Asplin
Journal:  Kidney Int       Date:  2007-11-28       Impact factor: 10.612

9.  Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.

Authors:  Kevin D Healy; Julia B Zella; Jean M Prahl; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  8 in total

1.  Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers.

Authors:  Viviane Barcellos Menon; Rosa Maria Affonso Moysés; Samirah Abreu Gomes; Aluizio Barbosa de Carvalho; Vanda Jorgetti; Ita Pfeferman Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 8.237

2.  Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.

Authors:  Nancy S Krieger; John R Asplin; Ignacio Granja; Felix M Ramos; Courtney Flotteron; Luojing Chen; Tong Tong Wu; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2019-05-17       Impact factor: 10.121

3.  Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.

Authors:  Nancy S Krieger; John R Asplin; Kevin K Frick; Ignacio Granja; Christopher D Culbertson; Adeline Ng; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

4.  Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Authors:  Kevin K Frick; John R Asplin; Christopher D Culbertson; Ignacio Granja; Nancy S Krieger; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-26

5.  Association study of DGKH gene polymorphisms with calcium oxalate stone in Chinese population.

Authors:  Yong Xu; Guohua Zeng; Zanlin Mai; Lili Ou
Journal:  Urolithiasis       Date:  2014-08-01       Impact factor: 3.436

Review 6.  Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.

Authors:  Kevin K Frick; Nancy S Krieger; David A Bushinsky
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-07       Impact factor: 2.894

7.  Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.

Authors:  Nancy S Krieger; John Asplin; Ignacio Granja; Luojing Chen; Daiana Spataru; Tong Tong Wu; Marc Grynpas; David A Bushinsky
Journal:  Kidney Int       Date:  2021-01-05       Impact factor: 10.612

8.  Integrative microRNA-gene expression network analysis in genetic hypercalciuric stone-forming rat kidney.

Authors:  Yuchao Lu; Baolong Qin; Henglong Hu; Jiaqiao Zhang; Yufeng Wang; Qing Wang; Shaogang Wang
Journal:  PeerJ       Date:  2016-03-31       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.